Biofilm Correlation and Validation

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

February 15, 2022

Primary Completion Date

May 15, 2022

Study Completion Date

November 8, 2023

Conditions
Wound Infection
Interventions
DEVICE

MolecuLight DX Imaging Device

The MolecuLight DX Imaging Device is a fluorescence imaging device intended to acquire images from wounds. This will not alter the participant's standard of care treatment.

Trial Locations (1)

L8R 2R3

The Mayer Institute, Hamilton

Sponsors

Lead Sponsor

All Listed Sponsors
lead

MolecuLight Inc.

INDUSTRY

NCT05196880 - Biofilm Correlation and Validation | Biotech Hunter | Biotech Hunter